Neonc Technologies (NASDAQ:NTHI) CEO Purchases $150,600.00 in Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour purchased 30,000 shares of the stock in a transaction dated Friday, November 13th. The stock was bought at an average cost of $5.02 per share, with a total value of $150,600.00. Following the completion of the purchase, the chief executive officer owned 3,353,000 shares in the company, valued at $16,832,060. The trade was a 0.90% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Neonc Technologies Stock Performance

NTHI stock traded up $0.06 during midday trading on Friday, hitting $4.91. 251,853 shares of the company’s stock were exchanged, compared to its average volume of 118,828. Neonc Technologies Holdings, Inc. has a one year low of $2.50 and a one year high of $11.38. The stock’s fifty day moving average price is $3.30 and its 200-day moving average price is $5.29.

Neonc Technologies (NASDAQ:NTHI) last released its quarterly earnings results on Thursday, November 5th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by ($0.03).

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. Bank of America Corp DE grew its holdings in shares of Neonc Technologies by 5.0% during the 1st quarter. Bank of America Corp DE now owns 235,396 shares of the company’s stock valued at $1,650,000 after purchasing an additional 11,108 shares during the last quarter. Global Retirement Partners LLC bought a new position in Neonc Technologies in the 2nd quarter valued at approximately $126,000. Westmount Partners LLC lifted its stake in Neonc Technologies by 355.2% in the 2nd quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock valued at $893,000 after purchasing an additional 153,858 shares during the last quarter. Finally, BlackRock Inc. bought a new position in Neonc Technologies in the 2nd quarter valued at approximately $815,000.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on NTHI shares. Zacks Research raised Neonc Technologies from a “strong sell” rating to a “hold” rating in a report on Thursday, November 5th. Weiss Ratings downgraded shares of Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, October 21st. Wall Street Zen upgraded shares of Neonc Technologies from a “sell” rating to a “hold” rating in a report on Saturday, November 7th. BTIG Research reissued a “buy” rating and issued a $15.00 price objective on shares of Neonc Technologies in a research report on Tuesday, September 8th. Finally, Roth Capital assumed coverage on shares of Neonc Technologies in a research note on Thursday, September 24th. They set a “buy” rating for the company. Four investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Neonc Technologies presently has an average rating of “Moderate Buy” and an average price target of $16.00.

About Neonc Technologies

NeOnc Technologies Holdings, Inc. is a biotechnology company developing treatments for brain tumors and other central nervous system cancers. Its research focuses on approaches intended to deliver therapies to the brain, where the blood-brain barrier can limit the effectiveness of conventional treatments. The company’s pipeline includes NEO100, a formulation of perillyl alcohol designed for intranasal delivery, and NEO212, a compound combining perillyl alcohol with temozolomide. These candidates are being developed for potential use in brain cancer treatment.